Open Government Portal

Found 10 records similar to Guidance for market authorization requirements for COVID-19 vaccines: Overview

Federal

Variant strains of SARS-CoV-2 are emerging that may affect the level of protection provided by currently authorized COVID-19 vaccines. As a result, manufacturers are adapting authorized COVID-19 vaccines to provide protection against infection and disease caused by virus variants.

Last Updated: Jul. 27, 2021
Date Published: Mar. 26, 2021
Organization: Health Canada
Formats: HTML
Keywords:  coronavirus, COVID-19, pandemic, drugs, medications, vaccines, market authorization, licensing, importing or selling
Federal

We are collaborating with other national regulatory authorities to align the requirements for evaluating, authorizing and post-market surveillance of variant COVID-19 vaccines as much as possible.

Last Updated: Jul. 28, 2022
Date Published: Mar. 26, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, SARS-CoV-2 virus, COVID-19 vaccines, COVID-19 drugs, market authorization requirements, vaccine manufacturers, requirements for vaccines, SARS-CoV-2 variants
Federal

This document provides guidance to vaccine manufacturers seeking authorization for their vaccine that targets the SARS-CoV-2 virus. This guidance applies to applications under the interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19.

Last Updated: Jul. 28, 2022
Date Published: Nov. 18, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, SARS-CoV-2 virus, COVID-19 vaccines, COVID-19 drugs, market authorization requirements, vaccine manufacturers, importation, sale and advertising
Federal

COVID-19 vaccines are safe and effective. Free vaccines will be available to everyone who lives in Canada over the course of 2021.
Until extensive immunization is achieved, public health measures will continue to be essential to minimize the spread of COVID-19 in Canada and save lives.

Last Updated: Feb. 15, 2021
Date Published: Jan. 27, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Canada, pandemic, Coronavirus, COVID-19, vaccine, Pfizer, Moderna
Federal

What you, and what communities can do to lower the spread of COVID-19 in settings including social services, workplaces, outdoors, community, religious, transport and remote and Indigenous communities.

Last Updated: Sep. 24, 2021
Date Published: Jun. 12, 2020
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Coronavirus, COVID-19, pandemic, measures, to reduce, COVID-19, COVID
Federal

Several different types of treatments for COVID-19 have been developed. Examples include drugs that reduce or stop the virus from multiplying in human cells and drugs that treat the symptoms of COVID-19.

Last Updated: Jun. 30, 2021
Date Published: Apr. 8, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, coronavirus, market authorization, COVID-19 Treatments, treatments, drugs, reduce or stop the virus from multiplying, treat the symptoms of COVID-19
Federal

Many potential drugs and treatments for use against COVID-19 are being evaluated in Canada and around the world. Several different types of treatments have been developed.

Last Updated: Aug. 26, 2021
Date Published: Jul. 30, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, drugs, treatments, COVID-19 treatments
Federal

This document provides guidance on establishment licensing, product quality and lot release to bring a COVID-19 vaccine to market in Canada.

Last Updated: Jul. 28, 2022
Date Published: Mar. 30, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, SARS-CoV-2 virus, COVID-19 vaccines, COVID-19 drugs, market authorization requirements, vaccine manufacturers, establishment licensing, product quality
Federal

Mathematical modelling of COVID-19 pandemic which uses mathematical equations to estimate how many cases of a disease may occur in the coming weeks or months.

Last Updated: Sep. 24, 2021
Date Published: Apr. 23, 2020
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  COVID-19, pandemic, epidemiological, social, economic dimension, of the outbreak, mathematical modelling, of COVID-19 outbreak, COVID-19
Federal

COVID-19 vaccine ingredients in the Pfizer-BioNTech, Moderna and AstraZeneca vaccines.

Last Updated: May 28, 2021
Date Published: May 7, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Covid-19, pandemic, covid vaccine, Pfizer covid vaccine, Pfizer COVID-19 vaccine, Moderna covid vaccine, Moderna COVID-19 vaccine, AstraZeneca covid vaccine, AstraZeneca COVID-19 vaccine
Date modified: